2020 PET/CT Imaging

Categories: All Products, Radiology Courses

Description
Additional information

2020 PET/CT Imaging

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

About This CME Teaching Activity

This CME activity is a clinical perspective of PET and PET/CT imaging from basic to advanced applications set in the context of disease detection and treatment planning.

Target Audience

This CME activity should benefit radiologists, oncologists and nuclear medicine physicians. The course should also prove valuable for physicians who order these studies.

Educational Objectives

At the completion of this CME teaching activity, you should be able to:

Apply state-of-the-art protocols to evaluate neurodegenerative disease, head and neck and cutaneous cancers to clinical practice.
Optimize PET and PET/CT imaging protocols for the detection and follow up of lymphoma and musculoskeletal tumors.
Describe the advantages and pitfalls of PET and PET/CT.
Differentiate normal variants and urgent findings on PET/CT.
Discuss the utility of PET/CT when used to evaluate cardiac disease, gastrointestinal, thyroid and prostate cancers.

Topics And Speakers:

Session 1

PET/CT Techniques and Reporting Principles
Erik S. Mittra, M.D., Ph.D.

PET/CT for Neurodegenerative Diseases
Gagandeep Choudhary, M.D.

PET/CT in Coronary Disease and Cardiac Sarcoidosis
Mark I. Travin, M.D.

Session 2

PET/CT for Non-Neurodegenerative Diseases
Gagandeep Choudhary, M.D.

PET/CT in Head and Neck Cancer
Don C. Yoo, M.D., FACR

PET/CT in Thyroid Cancer
Mark Tulchinsky, M.D., FACNM

Session 3

PET/CT in Lung Cancer
Don C. Yoo, M.D., FACR

PET/CT in Malignancy of the Breast and Female Pelvis
Katherine Zukotynski, M.D.

Qualitative and Quantitative Response Criteria
Erik S. Mittra, M.D., Ph.D.

Session 4

PET/CT in Infection and Inflammation Imaging
Don C. Yoo, M.D., FACR

PET/CT in Theragnostics
Erik S. Mittra, M.D., Ph.D.

Ga-68 and Lu-177 DOTATATE in Neuroendocrine Tumors
Katherine Zukotynski, M.D.

PET/CT in Lymphomas
Mark Tulchinsky, M.D., FACNM

Session 5

PET/CT in Prostate Cancer
Erik S. Mittra, M.D., Ph.D.

PET/CT in Skeletal Tumors: Primary and Metastatic
Katherine Zukotynski, M.D.

PET/CT in Cancers of the Skin
Mark Tulchinsky, M.D., FACNM